Sofinnova Investments' Jakob Dupont on the private markets in biotech
Jakob Dupont says he is focused on clinical stage companies or ones that are months within IND. He thinks the IPO market will be available for advanced companies in 2024.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
.png){kind=logo}
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants
bottom of page
Comentarios